BMAL1 ameliorates type 2 diabetes-induced cognitive impairment via AREG upregulation and PI3K/Akt/GSK-3β pathway activation

MLA

Jialu Xu, et al. “BMAL1 Ameliorates Type 2 Diabetes-Induced Cognitive Impairment via AREG Upregulation and PI3K/Akt/GSK-3β Pathway Activation.” Cell Communication and Signaling, vol. 23, no. 1, Jan. 2025, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12964-024-02019-5.

APA

Jialu Xu, Chunyu Li, Rongping Fan, Jiaxin Yin, Lei Xie, Xuemin Peng, Jing Tao, Weijie Xu, Shujun Zhang, Xiaoli Shi, Kun Dong, Xuefeng Yu, Xi Chen, & Yan Yang. (2025). BMAL1 ameliorates type 2 diabetes-induced cognitive impairment via AREG upregulation and PI3K/Akt/GSK-3β pathway activation. Cell Communication and Signaling, 23(1), 1–17. https://doi.org/10.1186/s12964-024-02019-5

Chicago

Jialu Xu, Chunyu Li, Rongping Fan, Jiaxin Yin, Lei Xie, Xuemin Peng, Jing Tao, et al. 2025. “BMAL1 Ameliorates Type 2 Diabetes-Induced Cognitive Impairment via AREG Upregulation and PI3K/Akt/GSK-3β Pathway Activation.” Cell Communication and Signaling 23 (1): 1–17. doi:10.1186/s12964-024-02019-5.